Clinical and virologic outcomes after starting HAART
Funding: PSP 26145 Puget Sound Partners for Global Health
PI: Nina Kim
Time Period: 07/01/08-03/31/10
The original adherence study (RCT) enrolled 400 HIV-infected Kenyan adults who consented to have blood collected and cyropreserved at months 0 (prior to initiation of HAART), 6, 12, and 18 for future analysis. We will perform hepatitis B (HB) serologic testing and HB viral quantitation and sequencing on these archived samples (stored in Seattle).
Link to Google Documents (For those with access): http://docs.google.com/?hl=en&tab=wo&pli=1#